vs

Side-by-side financial comparison of EnerSys (ENS) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.

PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $919.1M, roughly 1.2× EnerSys). EnerSys runs the higher net margin — 9.8% vs -127.8%, a 137.6% gap on every dollar of revenue. On growth, EnerSys posted the faster year-over-year revenue change (1.4% vs -2.5%). EnerSys produced more free cash flow last quarter ($171.3M vs $148.6M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs 0.5%).

EnerSys is a stored energy systems and technology provider for industrial applications. The company manufactures reserve-power and motive-power batteries, battery chargers, power equipment, battery accessories and outdoor equipment enclosures.

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...

ENS vs PRGO — Head-to-Head

Bigger by revenue
PRGO
PRGO
1.2× larger
PRGO
$1.1B
$919.1M
ENS
Growing faster (revenue YoY)
ENS
ENS
+4.0% gap
ENS
1.4%
-2.5%
PRGO
Higher net margin
ENS
ENS
137.6% more per $
ENS
9.8%
-127.8%
PRGO
More free cash flow
ENS
ENS
$22.7M more FCF
ENS
$171.3M
$148.6M
PRGO
Faster 2-yr revenue CAGR
PRGO
PRGO
Annualised
PRGO
1.3%
0.5%
ENS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ENS
ENS
PRGO
PRGO
Revenue
$919.1M
$1.1B
Net Profit
$90.4M
$-1.4B
Gross Margin
30.1%
32.6%
Operating Margin
13.5%
-116.0%
Net Margin
9.8%
-127.8%
Revenue YoY
1.4%
-2.5%
Net Profit YoY
-21.3%
-3093.9%
EPS (diluted)
$2.40
$-10.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENS
ENS
PRGO
PRGO
Q4 25
$919.1M
$1.1B
Q3 25
$951.3M
$1.0B
Q2 25
$893.0M
$1.1B
Q1 25
$974.8M
$1.0B
Q4 24
$906.2M
$1.1B
Q3 24
$883.7M
$1.1B
Q2 24
$852.9M
$1.1B
Q1 24
$910.7M
$1.1B
Net Profit
ENS
ENS
PRGO
PRGO
Q4 25
$90.4M
$-1.4B
Q3 25
$68.4M
$7.5M
Q2 25
$57.5M
$-8.4M
Q1 25
$96.5M
$-6.4M
Q4 24
$114.8M
$-44.4M
Q3 24
$82.3M
$-21.0M
Q2 24
$70.1M
$-108.4M
Q1 24
$60.9M
$2.0M
Gross Margin
ENS
ENS
PRGO
PRGO
Q4 25
30.1%
32.6%
Q3 25
29.1%
36.1%
Q2 25
28.4%
34.4%
Q1 25
31.2%
37.6%
Q4 24
32.9%
33.9%
Q3 24
28.5%
37.2%
Q2 24
27.9%
37.0%
Q1 24
27.9%
33.1%
Operating Margin
ENS
ENS
PRGO
PRGO
Q4 25
13.5%
-116.0%
Q3 25
9.7%
7.0%
Q2 25
9.7%
4.3%
Q1 25
13.5%
4.5%
Q4 24
15.7%
10.0%
Q3 24
11.2%
7.4%
Q2 24
10.7%
-2.5%
Q1 24
8.9%
-5.1%
Net Margin
ENS
ENS
PRGO
PRGO
Q4 25
9.8%
-127.8%
Q3 25
7.2%
0.7%
Q2 25
6.4%
-0.8%
Q1 25
9.9%
-0.6%
Q4 24
12.7%
-3.9%
Q3 24
9.3%
-1.9%
Q2 24
8.2%
-10.2%
Q1 24
6.7%
0.2%
EPS (diluted)
ENS
ENS
PRGO
PRGO
Q4 25
$2.40
$-10.23
Q3 25
$1.80
$0.05
Q2 25
$1.46
$-0.06
Q1 25
$2.39
$-0.05
Q4 24
$2.88
$-0.32
Q3 24
$2.01
$-0.15
Q2 24
$1.71
$-0.79
Q1 24
$1.48
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENS
ENS
PRGO
PRGO
Cash + ST InvestmentsLiquidity on hand
$450.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.9B
$2.9B
Total Assets
$4.0B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENS
ENS
PRGO
PRGO
Q4 25
$450.1M
Q3 25
$388.6M
$432.1M
Q2 25
$346.7M
$454.2M
Q1 25
$343.1M
$409.9M
Q4 24
$463.2M
$558.8M
Q3 24
$407.9M
$1.5B
Q2 24
$344.1M
$542.8M
Q1 24
$333.3M
$658.5M
Total Debt
ENS
ENS
PRGO
PRGO
Q4 25
Q3 25
Q2 25
Q1 25
$1.1B
Q4 24
Q3 24
Q2 24
Q1 24
$802.0M
Stockholders' Equity
ENS
ENS
PRGO
PRGO
Q4 25
$1.9B
$2.9B
Q3 25
$1.9B
$4.4B
Q2 25
$1.9B
$4.5B
Q1 25
$1.9B
$4.4B
Q4 24
$1.8B
$4.3B
Q3 24
$1.8B
$4.6B
Q2 24
$1.8B
$4.5B
Q1 24
$1.8B
$4.7B
Total Assets
ENS
ENS
PRGO
PRGO
Q4 25
$4.0B
$8.5B
Q3 25
$4.1B
$10.1B
Q2 25
$4.1B
$10.1B
Q1 25
$4.0B
$9.8B
Q4 24
$4.0B
$9.6B
Q3 24
$4.0B
$11.2B
Q2 24
$3.6B
$10.4B
Q1 24
$3.5B
$10.6B
Debt / Equity
ENS
ENS
PRGO
PRGO
Q4 25
Q3 25
Q2 25
Q1 25
0.57×
Q4 24
Q3 24
Q2 24
Q1 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENS
ENS
PRGO
PRGO
Operating Cash FlowLast quarter
$184.6M
$175.4M
Free Cash FlowOCF − Capex
$171.3M
$148.6M
FCF MarginFCF / Revenue
18.6%
13.4%
Capex IntensityCapex / Revenue
1.4%
2.4%
Cash ConversionOCF / Net Profit
2.04×
TTM Free Cash FlowTrailing 4 quarters
$441.3M
$145.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENS
ENS
PRGO
PRGO
Q4 25
$184.6M
$175.4M
Q3 25
$218.0M
$51.7M
Q2 25
$968.0K
$75.9M
Q1 25
$135.2M
$-64.5M
Q4 24
$81.1M
$312.6M
Q3 24
$33.6M
$42.2M
Q2 24
$10.4M
$9.5M
Q1 24
$-1.4M
Free Cash Flow
ENS
ENS
PRGO
PRGO
Q4 25
$171.3M
$148.6M
Q3 25
$197.1M
$29.8M
Q2 25
$-32.1M
$56.7M
Q1 25
$104.9M
$-90.0M
Q4 24
$56.8M
$274.9M
Q3 24
$3.3M
$15.1M
Q2 24
$-25.7M
$-18.9M
Q1 24
$-26.5M
FCF Margin
ENS
ENS
PRGO
PRGO
Q4 25
18.6%
13.4%
Q3 25
20.7%
2.9%
Q2 25
-3.6%
5.4%
Q1 25
10.8%
-8.6%
Q4 24
6.3%
24.2%
Q3 24
0.4%
1.4%
Q2 24
-3.0%
-1.8%
Q1 24
-2.4%
Capex Intensity
ENS
ENS
PRGO
PRGO
Q4 25
1.4%
2.4%
Q3 25
2.2%
2.1%
Q2 25
3.7%
1.8%
Q1 25
3.1%
2.4%
Q4 24
2.7%
3.3%
Q3 24
3.4%
2.5%
Q2 24
4.2%
2.7%
Q1 24
2.3%
Cash Conversion
ENS
ENS
PRGO
PRGO
Q4 25
2.04×
Q3 25
3.19×
6.89×
Q2 25
0.02×
Q1 25
1.40×
Q4 24
0.71×
Q3 24
0.41×
Q2 24
0.15×
Q1 24
-0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENS
ENS

Energy Systems$399.5M43%
Motive Power$352.0M38%
Services$92.6M10%
Transferred Over Time$38.2M4%
Other$36.8M4%

PRGO
PRGO

Consumer Self Care Americas$697.0M63%
Digestive Health$123.9M11%
Nutrition$108.3M10%
Healthy Lifestyle$94.8M9%
Pain And Sleep Aids$87.1M8%

Related Comparisons